ARCHIVES

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

This article is from The Cancer Letter archive.

Vol. 27 No. 18 | May 4, 2001

Download PDF Visit The Full Archive

Related Articles

NCI Gets Long List Of Consortium Center Needs, Including New Guidelines, Review, More “Glue”

September 14, 1984

ACS Recommends MRI For Some Women At High Risk

March 30, 2007

President, Congress Decry Practice Of “Drive-Through Mastectomies

February 21, 1997

New Awards for New Investigators To Replace R-23 Grants

November 8, 1985

Biology Societies Endorse Cloning Prohibition Act.

February 1, 2002

Centers Form Big Ten Research Consortium with Access to Over 30,000 New Patients a Year

May 31, 2013